Sorafenib Tosylate With or Without Everolimus in Treating Patients With Localized, Unresectable, or Metastatic Liver Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01005199
Recruitment Status : Completed
First Posted : October 30, 2009
Last Update Posted : April 15, 2016
Information provided by (Responsible Party):
Swiss Group for Clinical Cancer Research